Table 2.
Medication usage
| n (%) | Dosea | |
|---|---|---|
| Medication | ||
| Calcium supplementation (mg/d) | 113 (94) | 2048 ± 1507 (mode, 1500; range, 300–9450) |
| High-dose vitamin D (IU/wk) | 7 (6) | 135,714 ± 149,204 (mode, 50,000; range, 50,000–400,000) |
| Calcitriol (μg/d)b | 106 (88) | 0.50 ± 0.44 (mode, 0.25; range, 0.125–4.00) |
| Teriparatide (μg/d) | 2 (2) | Patient 74, 40 μg 5 d/wk, 60 μg 2 d/wk; patient 101, 20 μg daily |
| Thiazide | 24 (20) | |
| Hydrochlorothiazide (mg/d) | 23 (19) | 31 ± 15 (mode, 25; range, 12.5–50) |
| Chlorthalidone (mg/d) | 1 (1) | 25 |
| Medication management | ||
| Prescriber | ||
| Endocrinologist | 108 (90) | |
| Primary care physician | 12 (10) |
a
Excluding pediatric patients (<18 yr, n = 5).
b
Of patients prescribed calcitriol, 62% were taking it once daily, 27% twice daily, 5% three times daily, 2% four times daily, and 4% with alternating regimens.